Full Text View
Tabular View
No Study Results Posted
Related Studies
Vaccine Therapy or Observation in Treating Patients With Nasopharyngeal Cancer at High Risk for Recurrence
This study is ongoing, but not recruiting participants.
Study NCT00112541   Information provided by National Cancer Institute (NCI)
First Received: June 2, 2005   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Head and Neck Cancer
Additional conditions recognized in this trial
Head and Neck Neoplasms
Nasopharyngeal Neoplasms
Recurrence
More general conditions related to this trial
Disease Attributes
Nasopharyngeal Diseases
Neoplasms
Neoplasms by Site
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Pathologic Processes
Pharyngeal Diseases
Pharyngeal Neoplasms
Stomatognathic Diseases
Interventions listed in this trial
LMP-2:340-349 peptide vaccine
LMP-2:419-427 peptide vaccine
incomplete Freund's adjuvant
adjuvant therapy
Additional drug interventions recognized in this trial
Adjuvants, Immunologic
Freund's Adjuvant
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services